PALM BEACH GARDENS, FL--(Marketwire - June 30, 2010) -
| Highlighted Links |
|
|
AccuDial® Pharmaceutical, Inc. announced today the expansion of its board of directors with the appointment of five distinguished industry leaders. With the exciting success of its Children’s AccuDial family of pediatric, over-the-counter (OTC) products, which launched in Canada in January 2010, the private pharmaceutical company is moving forward aggressively in the dynamic global market.
New board member appointments include:
Schuyler Jungen Baab is president and chief executive officer of Pathfinders Government Relations, LLC, a highly respected, full-service government relations consulting practice in Washington, D.C. Mr. Baab is known in Washington circles for his high-profile accomplishments as deputy under-secretary of the U.S. Department of Health and Human Services (HHS), where he directed more than 10 regional HHS offices, and for his work as Wisconsin’s chief federal lobbyist under four-term Governor Tommy G. Thompson. His high-powered style and impeccable integrity facilitate strategic alliances at the highest levels of government, business, and politics to maximize business opportunities.
Stephen Key is a successful, award-winning inventor and entrepreneur, having licensed over 20 products in the past 30 years. A holder of over 13 patents, Mr. Key’s products have sold in Wal-Mart, 7-Eleven, Disney Stores, and at theme parks worldwide, and have been endorsed by basketball great Michael Jordan and Jeopardy! game show host Alex Trebek. Mr. Key’s innovative rotating label is the patented technology that AccuDial Pharmaceutical, Inc. has licensed for their weight-based dosing of liquid medications. He is recognized as an outstanding leader in the field of innovation.
Patrick Lonergan is a prominent industry executive and is formerly a 30-year veteran with Johnson & Johnson, where he held a number of leadership positions including vice president and general manager. While at Johnson & Johnson, he served as a member of the board of directors of Johnson & Johnson Products, Inc. and was chairman of the Health Care Division Management Committee. Mr. Lonergan has also served as vice chairman of the board of directors of the Consumer Healthcare Products Association, business chairman for the National Association of Chain Drug Stores, and chairman of the National Wholesale Druggists’ Association Industry Development Committee. He is the co-founder of Numark Laboratories, Inc. and has served as its president since January 1989. Mr. Lonergan currently serves on the board of directors of several publicly and privately held drug companies selling OTC products.
Christopher T. Metz is a managing director of Sun Capital Partners, a leading private investment firm in South Florida with approximately $8 billion of equity capital under management. Sun Capital affiliates have invested in more than 225 companies worldwide since its inception in 1995, with combined sales in excess of $40 billion and more than 170,000 employees. Mr. Metz has extensive operating leadership experience in consumer, industrial, and durable goods industries. Prior to joining Sun Capital Partners, he was president of the Hardware and Home Improvement Group of Black & Decker, holding several senior positions during his 13-year tenure. Mr. Metz was also president of Kwikset Corporation and Price Pfister, and was general manager of European Professional Power Tools and Accessories.
Matthew J. O’Connor is a dynamic entrepreneur who launched his career in the commercial insurance industry, quickly proving to be a formidable talent in a crowded competitive field. In 1997, he sold Premier Insurance Group to USI Insurance, a Goldman Sachs Company. Mr. O’Connor served as president/partner for USI Florida and delivered exceptional return and brand performance to the original investors. He was the founding partner of several successful start-ups, including the North Broward School, which was sold in 2005 to Wall Street investment firm Sterling Capital, to launch Ameritas Schools International. As president of AMG Enterprises, LLC, Mr. O’Connor leads a cutting-edge industry of boutique real estate development projects on coastal properties that continue to deliver value.
Robert Terwilliger, president and chief executive officer of AccuDial Pharmaceutical, Inc., was promoted to chairman of the board in April 2010, with former chairman Dr. Brian Kaplan accepting the role as chief medical advisor. In announcing the new board of director appointments, Mr. Terwilliger said, “It is truly a privilege for a relatively new pharmaceutical company such as AccuDial to have the counsel of five seasoned executives with incomparable industry experience. We look forward to working with them and the rest of our board members to pursue the dynamic growth opportunities and expansion of AccuDial’s products -- from OTC medications to prescription and institutional, as well as veterinary applications.”
Additional action taken by AccuDial’s board of directors included retaining the accounting and advisory firm of MarcumRachlin, a division of Marcum LLP, to provide assurance and tax services, and the international law firm of Morgan, Lewis & Bockius as special counsel in the areas of financing, merger and acquisitions, and certain regulatory matters.
Contact Information:
Enid Atwater
Venue Marketing Group
561.844.1778, ext. 21
enida@venueadv.com
Digg this
Bookmark with del.icio.us
Add to Newsvine
Technorati: 
